Physician profile
Eric M Freeman
NPI 1407597222
$2,345.67
in general payments reported to CMS, 2019-2025
9 companies · $1,102 in 2025
The $1,102 reported for 2025 was more than what 81% of Otolaryngology providers received nationally (typical 2025 total: $317).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2023: $671 · 2024: $573 · 2025: $1,102.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,346.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,345.67 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Inspire Medical Systems, INC. | $916.65 | 2023-2025 | Inspire |
| Davol INC. | $401.77 | 2025 | Arista |
| Genzyme Corporation | $372.60 | 2023-2025 | |
| Becton, Dickinson and Company | $309.12 | 2023-2024 | Arista Ah Flexitip |
| Regeneron Healthcare Solutions, INC. | $145.70 | 2023-2025 | Dupixent |
| Med-El Corporation | $102.18 | 2025 | Bci 602 Kit, Mi1250 Synchrony 2 Flexsoft |
| Janssen Pharmaceuticals, INC | $59.70 | 2023 | Xarelto |
| Karl Storz Endoscopy-America | $22.64 | 2023 | Hopkins |
| Stryker Corporation | $15.31 | 2025 | Audion Et Dilation System |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Eric Freeman listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.